← Leaderboards
In Kyoon Lyoo
University Of Utah
$1,991,834
Attributed
$3,983,668
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $776.7K · FY2008–19$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,983,668 · 1
By mechanism
R01$3,983,668 · 1
Top collaborators
- Perry Franklin Renshaw11 shared
Most similar at University Of Utah
Same institution · by research overlap
- Glen R Hanson$5,358,785
- Young-Hoon Sung$1,493,730
- Lisa G Aspinwall$1,272,185
- Kristen A Keefe$8,967,364
- Thomas M McIntyre$16,430,367
Others in their field
Top investigators on “Research Proposals”
- Lawrence Corey · Fred Hutchinson Cancer Center$716,063,957
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$527,082,145
- Eric S Lander · Whitehead Institute For Biomedical Res$477,076,839
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$388,083,462
- David R. Weir · University Of Michigan At Ann Arbor$387,892,407
Research focus
Research ProposalsPrefrontal CortexProgramsReportingNeurotoxicityPharmaceutical PreparationsBrain RegionDrug AbuseMultimodal ImagingMethamphetamineNeuroimagingNeuronsAdolescentNih Program AnnouncementsAwardAdultCollaborationsDiffusion Magnetic Resonance ImagingFundingGray MatterBrainInternationalAbstinenceResources
Grant awards (11)
CDP-choline treatment in amphetamine type stimulant-using adolescents$462,827
R01 · FY2019 · DA
CDP-choline treatment in amphetamine type stimulant-using adolescents$462,827
R01 · FY2018 · DA
CDP-choline treatment in amphetamine type stimulant-using adolescents$313,852
R01 · FY2018 · DA
CDP-choline treatment in amphetamine type stimulant-using adolescents$462,827
R01 · FY2017 · DA
CDP-choline treatment in amphetamine type stimulant-using adolescents$458,197
R01 · FY2016 · DA
CDP-choline treatment in amphetamine type stimulant-using adolescents$475,077
R01 · FY2015 · DA
Longitudinal neuroimaging of metamphetamine-dependent adolescents$261,153
R01 · FY2012 · DA
Longitudinal neuroimaging of metamphetamine-dependent adolescents$261,153
R01 · FY2011 · DA
Longitudinal neuroimaging of metamphetamine-dependent adolescents$269,230
R01 · FY2010 · DA
Longitudinal neuroimaging of metamphetamine-dependent adolescents$271,950
R01 · FY2009 · DA
Longitudinal neuroimaging of metamphetamine-dependent adolescents$284,575
R01 · FY2008 · DA